Alaunos Therapeutics, Inc.
TCRT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001107421
No open-market purchases or sales by Alaunos Therapeutics, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $204.4K in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding Alaunos Therapeutics, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 124 | 4 | 110 | −10 |
| Shares | 77.9M | 74.8K | 70.9M | −6.93M (−8.9%) |
| Value | $50.5M | $48.1K | $44.7M | −$5.81M (−11.5%) |
4 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 1,077,215 | $678.6K | 0.00% |
| Cerity Partners LLC | 41,000 | $25.8K | 0.00% |
| Act Wealth Management, LLC | 38,476 | $24.2K | 0.01% |
| Bank of Montreal | 14,622 | $9.62K | 0.00% |
| Sawtooth Solutions, LLC | 13,586 | $8.56K | 0.00% |
| Connectus Wealth, LLC | 10,000 | $6.30K | 0.00% |
| Psagot Value Holdings Ltd. / (Israel) | 5,115 | $3.00K | 0.00% |
Sold out (17)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Alyeska Investment Group, L.P. | 500,000 | $324.6K |
| Marshall Wace, LLP | 451,698 | $293.6K |
| Jane Street Group, LLC | 141,198 | $91.7K |
| Ergoteles LLC | 114,131 | $74.1K |
| Charles Schwab Investment Management Inc | 82,975 | $53.9K |
| Qube Research & Technologies Ltd | 53,320 | $34.6K |
| Mirabella Financial Services LLP | 48,720 | $31.6K |
| Y-Intercept (Hong Kong) Ltd | 42,154 | $27.4K |
| Sequoia Financial Advisors, LLC | 40,000 | $26.0K |
| Summit Trail Advisors, LLC | 25,378 | $16.5K |
| HRT Financial LP | 18,256 | $11.0K |
| Rockefeller Capital Management L.P. | 8,410 | $5.00K |
| Madden Securities Corp | 4,000 | $2.60K |
| GWM Advisors LLC | 550 | $357 |
| Money Concepts Capital Corp | 500 | $325 |
| The PNC Financial Services Group, Inc. | 200 | $130 |
| Addison Capital Co | 15,870 | – |
Not filed for Q1 2023 yet (4)
Institutions that held Alaunos Therapeutics, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Gamble Jones Investment Counsel | 61,000 | $39.6K |
| ARGI Investment Services, LLC | 13,000 | $8.00K |
| Cornerstone Planning Group LLC | 500 | $379 |
| Trustcore Financial Services, LLC | 250 | $162 |